Abstract
Chronic vascular rejection is a major cause of long-term graft failure after renal transplantation. We investigated the effect of the addition of misoprostol (200 μg four times daily) to standard immunosuppressive therapy on the outcome of chronic rejection in a double-blind, placebo-controlled trial. Patients had to fulfill predefined histological and clinical criteria. After an entry of 40 patients into the study (22 misoprostol, 18 placebo), the inclusion of additional patients was terminated because of a high incidence of withdrawal due to adverse effects. Of the patients who used their study medication for at least 3 months (16 misoprostol, 15 placebo), graft function deteriorated in all but 5 misoprostol-treated and all but 2 placebo-treated patients. There was no difference in dialysis-free survival. Withdrawal because of adverse effects (mainly gastrointestinal complaints) occurred in 3 cases in the placebo group and in 11 cases in the misoprostol group (P < 0.05). In conclusion, we found no evidence for a beneficial effect of misoprostol on the course of chronic renal allograft rejection, while use of the drug was accompanied by a high incidence of side effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bia MJ (1995) Nonimmunologic causes of late renal graft loss. Kidney Int 47: 1470–1480
Curtis LD, Anwar Buckels JA, Jones man G, McGregor (1993) Misoprostol tation. Transplant
Duffie GP, Romanelli RR, Ellis NK, Young MR, Wepsic HT (1988) The effects of E series prostaglandins on blastogenic responses in vitro and graft vs. host responses in vivo. Immunopharmacol Immunotoxicol 10: 597–615
Dunn J, Golden D, Van Buren CT, Lewis RM, Lawen J, Kahan BD (1990) Causes of graft loss beyond two years in the cyclosporine era. Transplantation 49: 349–353 9.
Garris RE, Kirkwood CF (1989) Misoprostol: a prostaglandin El analogue. Clin Pharm 8: 627–644
Hostetter TH (1994) Chronic transplant 10. rejection. Kidney Int 46: 266–279
Moran M, Mozes MF, Maddux MS, Veremis S, Bartkus C, Ketel B, Pollak R, Wallemark C, Jonasson O (1990) Prevention of acute graft rejection by the prostaglandin El analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. N Engl J Med 322: 1183–1188
Paller MS (1988) Effects of the prostaglandin El analog misoprostol on cyclosporine nephrotoxicity. Transplantation 45: 1126–1131
Paller MS, Manivel JC (1992) Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. Kidney Int 42: 1345–1354
Pouteil Noble C, Chapuis F, Berra N, Hadj Aissa A, Lacavalerie B, Lefrancois N, Martin X, Touraine JL (1994) Misoprostol in renal transplant recipients: a prospective, randomized, controlled study on the prevention of acute rejection episodes and cyclosporin A nephrotoxicity. Nephrol Dial Transplant 9: 552–555
Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD, Gores PF, Dunn DL, Sutherland DE, Najarian JS (1991) Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 214: 679–688
Tullius SG, Tilney NL (1995) Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59: 313–318
Wiederkehr JC, Dumble L, Pollak R, Moran M (1990) Immunosuppressive effect of misoprostol: a new synthetic prostaglandin El analogue. Aust N Z J Surg 60: 121–124
Wilkie ME, Beer JC, Newman D, Raftery MJ, Marsh FP (1992) Evidence that the risks of misoprostol outweigh its benefits in stable cyclosporine-treated renal allograft recipients. Transplantation 54: 565–567
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hilbrands, L.B., Rischen-Vos, J., Hené, R., Weimar, W., Assmann, K., Hoitsma, A.J. (1996). Randomized trial of misoprostol in patients with chronic renal transplant rejection. In: Mühlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-00818-8_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61024-3
Online ISBN: 978-3-662-00818-8
eBook Packages: Springer Book Archive